Discovery of a Stem-like T cell in type 1 diabetes holds potential for improving cancer immunotherapy
As an autoimmune disease, Type 1 diabetes raises important questions about immune cell activity that have broad implications for immunotherapy.
Materials provided by Memorial Sloan Kettering Cancer Center. Note: Content may be edited for style and length.
Source link aaaaa